- Poster presentation
- Open Access
Berardinelli-Seip syndrome in a Chinese boy with Seipin gene mutation: a case study and literature review of genotype-phenotype
© Huang et al; licensee BioMed Central Ltd. 2013
- Published: 3 October 2013
- Asian Population
- Phenotypic Heterogeneity
- Entire Code Region
- Autosomal Recessive Inheritance
Congenital generalized lipodystrophy (CGL), or Berardinelli-Seip syndrome, is a rare and heterogeneous disease of autosomal recessive inheritance characterized by the generalized absence of adipose tissue at birth and severe adverse metabolic consequences. The identified causative genes for CGL include 1-acylglycerol-3-phosphate O-acyltransferase 2 (AGPAT2), Berardinelli-Seip congenital lipodystrophy 2 (BSCL2 or Seipin), Caveolin-1 (CAV1) and polymerase I and transcript release factor (PTRF). Although more than 60 cases of CGL with different gene mutations have been found in Asian patients, only 7 patients were Chinese. Data are also limited regarding genotype-phenotype analysis in Asian CGL patients. Therefore, we aimed to analyze variations of two identified major causative genes, Seipin and AGPAT2, involved in CGL etiology in a mainland Chinese affected family and explore the genotype-phenotype of Berardinelli-Seip syndrome in Asian populations.
We report a detailed clinical and genetic analysis of a Chinese boy with CGL who was followed from infancy through preschool. Sequences of the entire coding region of Seipin and AGPAT2 were examined. Phenotypes in various Asian subtypes were compared and the related literature about Berardinelli-Seip syndrome was reviewed.
We identified a homozygous frameshift mutation (c.974-975insG) in the Seipin gene in the CGL-affected boy. His parents were heterozygous for the same mutation. No variation was found in the AGPAT2 gene.
In Asian populations, Seipin and PTRF are the main genes identified to date as being responsible for CGL and Seipin is a major causative gene. Genetic heterogeneity is accompanied by phenotypic heterogeneity.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.